Long-term safety and outcomes in hereditary tyrosinaemia type 1 with nitisinone treatment: a 15-year non-interventional, multicentre study

  1. Spiekerkoetter, U.
  2. Couce, M.L.
  3. Das, A.M.
  4. de Laet, C.
  5. Dionisi-Vici, C.
  6. Lund, A.M.
  7. Schiff, M.
  8. Spada, M.
  9. Sparve, E.
  10. Szamosi, J.
  11. Vara, R.
  12. Rudebeck, M.
Revista:
The Lancet Diabetes and Endocrinology

ISSN: 2213-8595 2213-8587

Ano de publicación: 2021

Volume: 9

Número: 7

Páxinas: 427-435

Tipo: Artigo

DOI: 10.1016/S2213-8587(21)00092-9 GOOGLE SCHOLAR